Cervical necrotizing fasciitis: descriptive, retrospective analysis of 59 cases treated at a single center. | Canada Hyperbarics Skip to main content
Retrospective Study European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - 2016

Cervical necrotizing fasciitis: descriptive, retrospective analysis of 59 cases treated at a single center.

Elander J, Nekludov M, Larsson A, Nordlander B, Eksborg S, Hydman J — European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - , 2016

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a retrospective, descriptive analysis of 59 patients with cervical necrotizing fasciitis treated at a single center between 1998 and 2014 to evaluate a newly introduced treatment strategy.

What They Found

The observed 3-month mortality rate was 10% (6 out of 59 patients). The most common initial infection foci were pharyngeal, dental, or hypopharyngeal, and Streptococcus milleri was the most frequent pathogen, identified in 66% of cases. A combined treatment of early surgical debridement and hyperbaric oxygen therapy appeared to reduce mortality compared to historical reports.

What This Means for Canadian Patients

Early and aggressive treatment, including surgical debridement and hyperbaric oxygen therapy, is vital for improving survival rates in patients with cervical necrotizing fasciitis. Patients with severe neck infections should seek prompt medical evaluation to ensure timely intervention and better outcomes.

Canadian Relevance

This study was conducted at a single center outside of Canada, so its direct relevance to the Canadian healthcare system and patient population is limited.

Study Limitations

As a retrospective, descriptive analysis from a single center, the study's findings may not be generalizable, and no identifiable factor was found to prognosticate outcome.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Infection
Source Pubmed
PubMed ID 27287509
Year Published 2016
Journal European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -
MeSH Terms Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Combined Modality Therapy; Debridement; Fasciitis, Necrotizing; Female; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Neck; Retrospective Studies

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.